Stocks and Investing Stocks and Investing
Fri, August 4, 2023

David Lebovitz Maintained (ALNY) at Strong Buy with Increased Target to $266 on, Aug 4th, 2023


Published on 2024-10-28 05:34:44 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Citigroup, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $265 to $266 on, Aug 4th, 2023.

David has made no other calls on ALNY in the last 4 months.



There are 4 other peers that have a rating on ALNY. Out of the 4 peers that are also analyzing ALNY, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $200 on, Thursday, July 13th, 2023
  • David Hoang of "SMBC Nikko" Initiated at Hold and Held Target at $220 on, Wednesday, April 26th, 2023


These are the ratings of the 2 analyists that currently disagree with David


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $405 on, Tuesday, July 25th, 2023
  • Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $250 on, Friday, May 5th, 2023
Contributing Sources